Domů › Rakovina jater (hepatocelulární karcinom) › Kalifornie › Orange
Klinické studie Rakovina jater (hepatocelulární karcinom) v Orange, CA
14 studií pro Rakovina jater (hepatocelulární karcinom) hledá účastníky v lokalitách v Orange a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
Probíhá náborFáze 1/2
- Research Facility, Orange
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Probíhá náborFáze 1/2
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
Probíhá náborFáze 2
- UC Irvine Health. Chao Family Comprehensive Cancer Center, Orange
Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial
Probíhá náborFáze 1/2
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
Probíhá nábor
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Probíhá náborFáze 1/2
- Children's Hospital of Orange County, Orange
Patient-Derived Xenografts to Reduce Cancer Health Disparities
Probíhá náborObservační studie
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Probíhá náborFáze 3
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Probíhá náborFáze 1
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
Probíhá náborFáze 1/2
- Children's Hospital Orange County, Orange
Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma
Probíhá náborFáze 2
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Probíhá náborFáze 1/2
- University of California Irvine Medical Center, Orange
Combination of TATE and PD-1 Inhibitor in Liver Cancer
Probíhá náborFáze 2
- University of California, Irvine, Orange
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Orange
Studie Rakovina jater (hepatocelulární karcinom) v jiných městech
- Houston, TX31 studií
- New York City, NY24 studií
- Dallas, TX19 studií
- Los Angeles, CA19 studií
- Boston, MA18 studií
- Cleveland, OH18 studií
- Chicago, IL16 studií
- Philadelphia, PA16 studií
- Pittsburgh, PA15 studií
- San Francisco, CA14 studií
- Jacksonville, FL14 studií
- San Antonio, TX13 studií
Další studie v Orange
- Nemalobuněčný plicní karcinom25 studií
- Metastatický karcinom20 studií
- Kolorektální karcinom16 studií
- Rakovina vaječníků16 studií
- Rakovina slinivky břišní15 studií
- Melanom14 studií
- Rakovina prsu14 studií
- Rakovina plic14 studií
- Rakovina prostaty14 studií
- Rakovina žaludku13 studií
- Rakovina (všechny typy)13 studií
- Akutní myeloidní leukemie13 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.